(Q57988152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25752281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Reproductive endocrinology: Menopausal hormone therapy-ovarian cancer risk revisited (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25752281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25752281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Rodney J Baber

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25752281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Susan R. Davis

series ordinal

1

0 references

Rodney Baber

series ordinal

2

0 references

publication date

10 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25752281%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Endocrinology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25752281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25752281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25752281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

322-323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25752281%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrendo.2015.33

2 March 2020

exact match

0 references

cites work

Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.33

Overdiagnosis and overtreatment in cancer: an opportunity for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.33

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.33

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.33

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.33

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.33

Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.33

The domestic chicken: Causes and consequences of an egg a day.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.33

Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25752281

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRENDO.2015.33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25752281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference